NZ182341A - Solid solution or dispersion of ergot alkaloids as pharmaceutical actiue agent - Google Patents
Solid solution or dispersion of ergot alkaloids as pharmaceutical actiue agentInfo
- Publication number
- NZ182341A NZ182341A NZ182341A NZ18234176A NZ182341A NZ 182341 A NZ182341 A NZ 182341A NZ 182341 A NZ182341 A NZ 182341A NZ 18234176 A NZ18234176 A NZ 18234176A NZ 182341 A NZ182341 A NZ 182341A
- Authority
- NZ
- New Zealand
- Prior art keywords
- actiue
- dispersion
- pharmaceutical
- agent
- solid solution
- Prior art date
Links
- 229960003133 ergot alkaloid Drugs 0.000 title 1
- 239000007962 solid dispersion Substances 0.000 title 1
- 239000006104 solid solution Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2546577A DE2546577B2 (de) | 1975-10-17 | 1975-10-17 | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ182341A true NZ182341A (en) | 1978-09-20 |
Family
ID=5959411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ182341A NZ182341A (en) | 1975-10-17 | 1976-10-15 | Solid solution or dispersion of ergot alkaloids as pharmaceutical actiue agent |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPS5854122B2 (OSRAM) |
| AT (1) | AT362510B (OSRAM) |
| AU (1) | AU508628B2 (OSRAM) |
| BE (1) | BE847368A (OSRAM) |
| CA (1) | CA1079641A (OSRAM) |
| CH (1) | CH643737A5 (OSRAM) |
| CS (1) | CS199647B2 (OSRAM) |
| DE (1) | DE2546577B2 (OSRAM) |
| DK (1) | DK146194C (OSRAM) |
| ES (1) | ES452420A1 (OSRAM) |
| FI (1) | FI762875A7 (OSRAM) |
| FR (1) | FR2327764A1 (OSRAM) |
| GB (1) | GB1560406A (OSRAM) |
| GR (1) | GR61268B (OSRAM) |
| HK (1) | HK3183A (OSRAM) |
| HU (1) | HU172533B (OSRAM) |
| IE (1) | IE43778B1 (OSRAM) |
| IL (1) | IL50686A (OSRAM) |
| MY (1) | MY8400063A (OSRAM) |
| NL (1) | NL184558C (OSRAM) |
| NO (1) | NO144468C (OSRAM) |
| NZ (1) | NZ182341A (OSRAM) |
| PH (1) | PH14513A (OSRAM) |
| PT (1) | PT65719B (OSRAM) |
| SE (1) | SE430379B (OSRAM) |
| SG (1) | SG63082G (OSRAM) |
| SU (1) | SU1165223A3 (OSRAM) |
| ZA (1) | ZA766166B (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1572226A (en) * | 1977-11-03 | 1980-07-30 | Hoechst Uk Ltd | Pharmaceutical preparations in solid unit dosage form |
| US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
| DK154607C (da) * | 1978-12-21 | 1989-06-05 | Sandoz Ag | Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider |
| FR2454804B1 (fr) * | 1979-04-26 | 1986-11-21 | Sanofi Sa | Medicament a base de dihydroergotoxine et son procede de preparation |
| US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
| US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
| HU198844B (en) * | 1984-06-14 | 1989-12-28 | Sandoz Ag | Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient |
| ES2039287T3 (es) * | 1987-01-14 | 1993-09-16 | Ciba-Geigy Ag | Procedimiento para la obtencion de un sistema terapeutico peroral para productos activos dificilmente solubles. |
| FR2610827B1 (fr) * | 1987-02-18 | 1991-09-13 | Pf Medicament | Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication |
| US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
| DE4401646A1 (de) * | 1994-01-21 | 1995-07-27 | Krewel Werke Gmbh | Optimal freisetzende Kava-Extrakte |
| US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
| CA2315685C (en) * | 1997-12-22 | 2008-02-05 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
| US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
| US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
| US7771746B2 (en) | 1999-12-03 | 2010-08-10 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| EP1235574B1 (en) * | 1999-12-03 | 2005-02-02 | Polichem S.A. | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| US7135436B2 (en) | 2003-05-05 | 2006-11-14 | J.F. Daley International, Ltd. | Solid algicide, preparation and usage in recirculating water |
| DE60309356T2 (de) * | 2003-06-27 | 2007-08-30 | Bioprogress S.P.A. | Zusammensetzung, durch zusammen vermahlen eines wirkstoffes mit einem n-vinyl-2-pyrrolidon/vinylacetatkopolymers erhältlich |
| WO2016198983A1 (en) | 2015-06-09 | 2016-12-15 | Bend Research Inc. | Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1175430A (en) * | 1966-04-07 | 1969-12-23 | Sandoz Ltd | Pharmaceutical Compositions containing Ergot Alkaloids |
-
1975
- 1975-10-17 DE DE2546577A patent/DE2546577B2/de not_active Withdrawn
-
1976
- 1976-10-01 CH CH1244876A patent/CH643737A5/de not_active IP Right Cessation
- 1976-10-08 NO NO763446A patent/NO144468C/no unknown
- 1976-10-08 DK DK454176A patent/DK146194C/da not_active IP Right Cessation
- 1976-10-08 SE SE7611189A patent/SE430379B/xx not_active IP Right Cessation
- 1976-10-08 FI FI762875A patent/FI762875A7/fi not_active Application Discontinuation
- 1976-10-13 NL NLAANVRAGE7611295,A patent/NL184558C/xx not_active IP Right Cessation
- 1976-10-14 CA CA263,423A patent/CA1079641A/en not_active Expired
- 1976-10-14 PH PH19008A patent/PH14513A/en unknown
- 1976-10-14 FR FR7630866A patent/FR2327764A1/fr active Granted
- 1976-10-15 AT AT767976A patent/AT362510B/de not_active IP Right Cessation
- 1976-10-15 AU AU18754/76A patent/AU508628B2/en not_active Expired
- 1976-10-15 BE BE171578A patent/BE847368A/xx not_active IP Right Cessation
- 1976-10-15 IE IE2282/76A patent/IE43778B1/en not_active IP Right Cessation
- 1976-10-15 SU SU762412401A patent/SU1165223A3/ru active
- 1976-10-15 NZ NZ182341A patent/NZ182341A/xx unknown
- 1976-10-15 HU HU76SA00002985A patent/HU172533B/hu not_active IP Right Cessation
- 1976-10-15 GB GB42907/76A patent/GB1560406A/en not_active Expired
- 1976-10-15 ES ES452420A patent/ES452420A1/es not_active Expired
- 1976-10-15 CS CS766685A patent/CS199647B2/cs unknown
- 1976-10-15 PT PT65719A patent/PT65719B/pt unknown
- 1976-10-15 ZA ZA00766166A patent/ZA766166B/xx unknown
- 1976-10-15 IL IL50686A patent/IL50686A/xx unknown
- 1976-10-16 GR GR51952A patent/GR61268B/el unknown
- 1976-10-16 JP JP51123463A patent/JPS5854122B2/ja not_active Expired
-
1982
- 1982-12-23 SG SG630/82A patent/SG63082G/en unknown
-
1983
- 1983-01-20 HK HK31/83A patent/HK3183A/xx unknown
-
1984
- 1984-12-30 MY MY63/84A patent/MY8400063A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ182341A (en) | Solid solution or dispersion of ergot alkaloids as pharmaceutical actiue agent | |
| JPS51114497A (en) | Preparation of stable dispersion | |
| GB1518444A (en) | N-phenyl-imidazolidine derivatives processes for preparing them and pharmaceutical compositions containing them | |
| GR59797B (en) | Preparation process of thieno-pyridine derivatives | |
| PT65208A (en) | Process of preparation of rifamycin compounds | |
| JPS5283331A (en) | Nnthiolcarbonyl derivatives of nnphosphonomethylglycin | |
| AU501974B2 (en) | Organophosporos derivatives of benztriazole | |
| NZ180785A (en) | Preparation of 5-aroyl-1-lower alkylpyr-rolf-2-acetic acid derivatives | |
| IL51017A0 (en) | The preparation of certain penicillin derivatives | |
| JPS51129477A (en) | Preparation of solid polymer of monooalphaaolefin | |
| IL49668A0 (en) | Stable solutions of ergot alkaloids,their preparation and pharmaceutical compositions comprising them | |
| JPS5264415A (en) | Preparation of solvent | |
| GB1545939A (en) | Derivatives of imidazole processes for their preparation and pharmaceutical compositions containing them | |
| JPS5212181A (en) | Derivatives of quinoxaline | |
| JPS5686116A (en) | Stable solution of hydrogenated ergot alkaloids | |
| JPS5277083A (en) | Nnacyl derivatives of thienamycine | |
| GB1557331A (en) | Pharmaceutical compositions containing an ergot alkaloid and heparing | |
| GR59319B (en) | Preparation process of azabicycloalkanes | |
| JPS51138695A (en) | Production of becyclic derivative of 77acylamidee33 cephemm44carboxylic acid and antiibacterial agent containing same | |
| JPS51145547A (en) | Safety agent of naphthofuranilnaphtol | |
| GR62855B (en) | Preparation process of 5-fluorouracil derivatives | |
| CS184793B2 (en) | Method of preparation of the stabil pharmaceutic agent containing the chelocardine | |
| JPS5273882A (en) | Preparation of 22substitutedd55 fluoropyrimidinee44one derivatives | |
| JPS5260896A (en) | Preparation of stable dispersion | |
| GB1517614A (en) | Separation of diindole alkaloids |